CONCERNING COVERAGE FOR BIOMARKER TESTING FOR EARLY DETECTION AND MANAGEMENT FOR CANCER DIAGNOSES.
Bill status
signed
all 5 stages cleared
Introduction
Jan 2023
Committee Review
Mar 2023
House Passage
Mar 2023
Senate Passage
Mar 2023
Signed into Law
Apr 2023
Introduced Jan 12, 2023
Signed Apr 4, 2023
Floor votes · House Mar 13, 2023
How they voted
This bill passed the Senate by voice vote (no roll call recorded).
Full legislative history
Actions timeline
Total actions
19
Key actions
7
Committee
2
Amendments
2
Apr 4, 2023
Signed into law
Notification that HB1121 is now Act 429
lower
Mar 29, 2023
Lower · Passed
Returned From the Senate as passed.
lower
Mar 29, 2023
Upper · Passed
Returned to the House as passed.
upper
Mar 29, 2023
Upper · Passed
Read the third time and passed.
upper
Mar 28, 2023
Upper · Passed
Returned by the Committee, with the recommendation that it Do Pass
upper
Mar 13, 2023
Lower · Passed
Read the third time and passed and ordered transmitted to the Senate.
lower
Mar 8, 2023
Lower · Passed
Returned by the Committee Do Pass
lower
Feb 28, 2023
Introduced
Amendment No. 2 read and adopted and the bill ordered engrossed.
lower
Feb 15, 2023
Introduced
Amendment No. 1 read and adopted and the bill ordered engrossed.
lower
Jan 12, 2023
Introduced
Filed
lower
2 primary · 6 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HB 1121
Scope: AR
Hi! I can help you understand HB 1121. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline